AstraZeneca is a leader in cancer treatments with FDA-approved drugs. Read why AZN stock is still a 'Buy' and why the company’s future looks bright.

Norfolk entrepreneur Tait Pollack from Norwich has credited sleep for saving his life after recovering from a life-threating illness following ...

WASHINGTON: The Central Intelligence Agency on Saturday shifted its official stance on the origin of COVID-19, saying that it ...

Amgen AMGN reported fourth-quarter 2024 adjusted earnings of $5.31 per share, which beat the Zacks Consensus Estimate of ...

Sanofi SNY and Roche RHHBY announced their fourth-quarter and full-year 2024 results. Novo Nordisk’s NVO novel obesity ...

Biopharma executives shared their thoughts on the potential impacts of the new administration; Annalee Armstrong recaps JPM ...

COVID-19 vaccines were not associated with increased risk for thyroid diseases but were associated with increased risk for exacerbated hypothyroidism.

In the Phase I dose escalation portion, which evaluated the combination in participants with small cell lung cancer, the ...

Nanexa AB announces that the phase I study with NEX-22, the company's one-month formulation of liraglutide, will resume with further dose escalation with an expected start in the first quarter of 2025 ...

February is observed as American Heart Month, a period dedicated to raising awareness about heart health. The first American Heart ...

Several medicines are poised to reach new heights after winning key endorsements from European drug regulators. | Among those ...